"Given that prevalence of people with T1D is projected to increase in all countries to up to 17.5 million cases in 2040, our results provide a warning for substantial negative implications for societies and healthcare systems," said Graham Ogle from Sydney Medical School, University of Sydney, who is, one of the authors of the study.
